San Camillo IRCCS
San Camillo IRCCS is an Italian Ministry of Health-accredited neurorehabilitation hospital and research institute in Venice serving neurological and oncology patients through inpatient, outpatient, and telerehabilitation services, integrated with a 2,000+ sample biobank and funded by SSN reimbursement and public research grants.
- Company typePrivate
- Founded2005
- HeadquartersLido, Italy
- Headcount251–500
- GTM typeB2C
- OfferingServices
What San Camillo IRCCS does
San Camillo IRCCS S.r.l. Società Unipersonale is an Italian scientific research and care institute (Istituto di Ricovero e Cura a Carattere Scientifico, IRCCS) accredited by the Italian Ministry of Health and specialized in neurorehabilitation. The institute is headquartered at the Lido di Venezia facility (Via Alberoni 70) and operates a secondary research site at Ospedale Villa Salus in Mestre, with an EU/State Relations office in Brussels. It serves patients with neurological conditions including stroke, traumatic brain and spinal injuries, multiple sclerosis, ALS, Parkinson's disease, brain tumors, and various dementias, as well as oncology patients experiencing cognitive impairment from cancer treatment. The business model is a hybrid of public clinical service delivery (Italian National Health Service reimbursement), government-funded research (Ministry of Health grants, PNRR, FISM), and donation revenue (5x1000 tax designation).
The institute's technology stack includes high-density 128-channel EEG, magnetoencephalography (MEG), robotics, virtual reality rehabilitation systems, a non-invasive neurostimulation clinic (NeuroStim), a telerehabilitation platform for home-based monitoring, and a Biobanca (BBMRNR) holding over 2,000 biological samples from neurodegenerative disease patients, integrated into the BBMRI.it national biobanking network. Clinical operations span inpatient hospitalization, an outpatient poliambulatorio with 10 specialty clinics, and clinical trial recruitment. Wholly owned by Fondazione Villa Salus (controlled by the Congregazione delle Suore Mantellate Serve di Maria di Pistoia), the institute is part of the IRCCS Network of Neuroscience and Rehabilitation, holds CORIS consortium membership, and maintains research collaborations with Ca' Foscari, Kansai Medical University, Ghent, Oxford, and Radboud universities. Recent strategic moves include the 2025 partnership to establish a Venice biomedical research hub, the parent foundation's 2025 acquisition of Ospedale San Raffaele Arcangelo Fatebenefratelli, the 2024 Venice historic-center outpatient expansion, and the launch of the NeuroStim neurostimulation service.
San Camillo IRCCS firmographics
Firmographics- Name
- San Camillo IRCCS
- Legal name
- San Camillo IRCCS S.r.l. Società Unipersonale
- Website
- https://hsancamillo.it
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- San Camillo IRCCS is an Italian Ministry of Health-accredited neurorehabilitation hospital and research institute in Venice serving neurological and oncology patients through inpatient, outpatient, and telerehabilitation services, integrated with a 2,000+ sample biobank and funded by SSN reimbursement and public research grants.
- Ownership category
- akta.pro rank
San Camillo IRCCS industry classification
Industry- Product category
- Neurorehabilitation Hospital Services
- NAICS
- Nursing Care Facilities (Skilled Nursing Facilities) (62311), Nursing and Residential Care Facilities (623), Services for the Elderly and Persons with Disabilities (62412)
- SIC
- Services-Skilled Nursing Care Facilities (8051), Services-Specialty Outpatient Facilities, Nec (8093), Services-Home Health Care Services (8082), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Neurorehabilitation Centers (HLAFAFAH)
- akta.pro secondary industries
- Inpatient Rehabilitation Facilities (IRF) (HLAFAFAA), Inpatient Rehabilitation Hospitals (IRFs) (HLAFAHAG)
Keywords
Where San Camillo IRCCS is headquartered
LocationHeadquarters
- HQ city
- Lido
- HQ country
- Italy
- HQ region
- Europe
Offices3 records
Markets served
San Camillo IRCCS business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- National Health Service (SSN) Reimbursement: As an accredited IRCCS, the hospital receives reimbursement from the Italian National Health Service for clinical services provided to patients
- Government Research Grants: Funding from Ministry of Health, PNRR (Piano Nazionale di Ripresa e Resilienza), and FISM (Fondazione Italiana Sclerosi Multipla) for specific research projects. Recent grants exceed 1 million euros for dysphagia and multiple sclerosis research projects
- 5×1000 Tax Donation: Italian tax designation program where taxpayers can donate 0.5% of taxes to the institute. Raised 42,000 euros in 2025 for neurorehabilitation research
Go-to-market motion1 record
Distribution channels5 records
Marketing channels7 records
San Camillo IRCCS product offering
Product offeringCore offering
San Camillo IRCCS is a Ministry of Health-accredited scientific research and care institute (IRCCS) that delivers comprehensive inpatient and outpatient neurorehabilitation services for patients with neurological conditions, including stroke, traumatic brain and spinal injuries, multiple sclerosis, ALS, Parkinson's disease, and brain tumors. The institute pairs this clinical care with an active scientific research program, a 2,000+ sample biobank, a NeuroStim neurostimulation clinic, and a telerehabilitation platform for home-based recovery.
Product overview
San Camillo IRCCS is a specialized neurorehabilitation hospital and research institute (IRCCS) offering comprehensive healthcare and research services. The institution operates as a single integrated hospital providing inpatient neurorehabilitation, outpatient clinic services (Poliambulatorio), and specialized neurostimulation (NeuroStim). Its research infrastructure includes the Biobanca (BBMRNR) for biological samples, multiple research laboratories, and clinical studies including stroke rehabilitation programs. The institution also runs citizen engagement programs (Rete Cittadini per la Ricerca) and provides training through ECM courses. Services are delivered across the Venice Lido facility in synergy with Villa Salus hospital and partner institutions.
Differentiator
Problem solved
Functional benefit
Products and services
- Neuroriabilitazione (Neurorehabilitation Services) Comprehensive inpatient and outpatient neurorehabilitation services for neurological patients, specializing in motor, cognitive, and communicative rehabilitation for conditions including stroke, traumatic brain and spinal injuries, multiple sclerosis, ALS, Parkinson's disease, and brain tumors.
- Poliambulatorio (Outpatient Clinic) Outpatient specialist services offering multiple medical specialties across 10 clinics, providing neurological consultations, ongoing rehabilitation, and monitoring for outpatients.
- NeuroStim - Ambulatorio di Neurostimolazione (Neurostimulation Clinic) Innovative and painless brain stimulation service for treating depression, addictions, and supporting post-stroke and Parkinson's rehabilitation. Established as the first synergy between Ospedale San Raffaele Arcangelo and San Camillo IRCCS.
- Studio Clinico Riabilitazione Post-Ictus (Post-Stroke Clinical Study) Free clinical study for stroke patients focused on supporting motor and cognitive recovery after the acute phase through a 12-week home rehabilitation program including exercises, smartphone activities, and remote monitoring.
- Biobanca BBMRNR - Malattie Rare e Neuro Riabilitazione (BBMRNR Biobank) Biological samples bank containing over 2,000 samples of neurodegenerative diseases including Parkinson's, multiple sclerosis, various forms of dementia, and post-stroke outcomes, supporting research in rare diseases and neurorehabilitation.
- Rete Cittadini per la Ricerca (Citizen Research Network) Citizen research network enabling public participation in scientific progress and contributing to improving future healthcare treatments.
Quantifiable outcome
- 42,000 euros raised through 5x1000 donations in 2025, demonstrating community and patient trust
- +1 more outcomes
Companies that use San Camillo IRCCS
Customer profileSegments4 records
Ideal customer profiles3 records
San Camillo IRCCS technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
San Camillo IRCCS partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core, minor and major.
- Congregazione delle Suore Mantellate Serve di Maria di PistoiacoreReligious congregation that owns Fondazione Villa Salus and exercises direction and coordination over San Camillo IRCCS and affiliated healthcare facilities. Acquired San Camillo management in 2019.
- Ca' Foscari UniversitycoreStrategic partnership to transform Venice into a biomedical research hub. Includes opening a research hub at Ca' Bottacin and a joint PhD program with Kansai Medical University. Focus on nanotechnologies, regenerative medicine, and neurosciences for treating neurodegenerative diseases like Parkinson's and multiple sclerosis.
- Kansai Medical University of OsakacoreInternational partnership with Japanese university for joint research in nanotechnologies applied to neurosciences, regenerative medicine, and neurodegenerative disease treatment. Includes joint PhD program with Ca' Foscari University.
- Poliambulatorio S. Marina and Centro Medico S. LucaminorHealthcare collaboration with clinics in Venice historic center near Rialto. Founded in 2014 by Dr. Paola Ruetta Fabbian, they began collaboration with Fondazione Villa Salus in 2024 to expand services, integrating with Villa Salus and San Camillo IRCCS hospital services.
- UniCamillus International Medical UniversityminorSan Camillo IRCCS hosts a new seat of the Faculty of Medicine and Surgery of UniCamillus, authorized by the Ministry. Enables medical education in the facility.
- CORIS (Consorzio per la Ricerca Sanitaria)minorSan Camillo joined CORIS to strengthen territorial connections. Consortium supports scientific research promotion and fundraising with Regione Veneto backing.
- IRCCS Istituto di Candiolo (Turin)majorCollaborative partnership in the ODEON project - oncological research project on breast cancer focusing on quality of life during and after treatment. Multi-center research collaboration.
- Fondazione Villa SaluscoreWorks in close synergy with Ospedale Classificato Villa Salus in Mestre. Both institutions are under the direction and coordination of Suore Mantellate Serve di Maria of Pistoia. Villa Salus acquired management of San Camillo IRCCS in August 2019.
- Ospedale San Raffaele Arcangelo (Fatebenefratelli)majorFondazione Villa Salus acquired this hospital in June 2025, bringing it into the healthcare network with San Camillo IRCCS and Villa Salus. Enables first synergy including the NeuroStim neurostimulation clinic.
- Ghent UniversityminorInternational academic collaboration in research and knowledge exchange in neuroscience and neurorehabilitation fields.
- Oxford UniversityminorInternational academic collaboration in research and knowledge exchange in neuroscience and neurorehabilitation fields.
- Radboud UniversityminorInternational academic collaboration in research and knowledge exchange in neuroscience and neurorehabilitation fields.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
San Camillo IRCCS competitors and assessment
Company assessmentDirect peers
- IRCCS Fondazione Santa Lucia: Italian IRCCS in Rome dedicated to neurorehabilitation and neuroscience research; same accreditation status (Ministry of Health), similar focus on stroke, TBI, and neurodegenerative disease, with comparable inpatient, outpatient, and research infrastructure — the closest direct domestic peer.
- IRCCS Centro Neurolesi Bonino Pulejo: Italian IRCCS based in Messina focused on neurological disease and neurorehabilitation with embedded research laboratories. Same accreditation, similar patient population, and overlapping technology stack (advanced neuroimaging, robotics) — directly comparable national competitor.
- Institut Guttmann: Barcelona-based hospital specialized in neurorehabilitation for spinal cord injury, brain damage, and other neurological conditions. Operates inpatient and outpatient services combined with a research institute, closely paralleling San Camillo's integrated care-plus-research model.
- Craig Hospital: Denver, Colorado specialty hospital for spinal cord injury and traumatic brain injury rehabilitation with strong research program. Highly comparable patient population, length-of-stay model, and integration of research into clinical care.
- Burke Neurological Institute: Research institute affiliated with Weill Cornell focused on neural recovery and repair in stroke, TBI, and neurodegenerative disease. Comparable scientific focus on neurorecovery, though lighter on inpatient clinical operations than San Camillo.
Broad incumbents
- Shirley Ryan AbilityLab: US research hospital in Chicago (formerly Rehabilitation Institute of Chicago) focused on physical medicine and rehabilitation with embedded research. Larger scale and broader rehab focus but directly comparable model of integrating clinical neurorehabilitation with a science-driven translational agenda.
- Kessler Institute for Rehabilitation: One of the largest US inpatient rehabilitation hospital networks with strong neurological rehabilitation programs. Comparable inpatient neurorehabilitation service line and patient mix, though operates at significantly larger scale and as part of a broader health system.
- TIRR Memorial Hermann: Houston-based rehabilitation hospital recognized for neurorehabilitation (stroke, brain injury, spinal cord injury). Comparable inpatient specialization and research affiliations, embedded within a large US hospital system.
Regional players
- National Rehabilitation Hospital (Dublin): Ireland's principal complex specialist rehabilitation hospital providing inpatient and outpatient neurorehabilitation services with a research office. Directly comparable model as a public system-funded neurorehab hospital, but serving a different national market.
- Royal Hospital for Neuro-disability: UK charity-run hospital in London providing specialist care and rehabilitation for adults with severe neurological conditions. Comparable patient population (complex neurological needs) and integrated care-research model, though UK-focused and non-profit governance like San Camillo.
Market position
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
San Camillo IRCCS social profiles
Digital presenceSan Camillo IRCCS compliance and trust
Trust signalCompliance2 records
San Camillo IRCCS financial estimates
Financial estimateRevenue estimate
Valuation estimate
San Camillo IRCCS leadership team
Management profileNumber of profiles
Profiles6 records
San Camillo IRCCS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
San Camillo IRCCS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about San Camillo IRCCS
What does San Camillo IRCCS do?
San Camillo IRCCS is a Ministry of Health-accredited scientific research and care institute (IRCCS) that delivers comprehensive inpatient and outpatient neurorehabilitation services for patients with neurological conditions, including stroke, traumatic brain and spinal injuries, multiple sclerosis, ALS, Parkinson's disease, and brain tumors. The institute pairs this clinical care with an active scientific research program, a 2,000+ sample biobank, a NeuroStim neurostimulation clinic, and a telerehabilitation platform for home-based recovery.
Is San Camillo IRCCS a public or private company?
San Camillo IRCCS is a private company. It is classified as corporate owned and is currently operating.
When was San Camillo IRCCS founded?
San Camillo IRCCS was founded in 2005. It employs 251 to 500 people.
Where is San Camillo IRCCS based?
San Camillo IRCCS is headquartered in Lido, Italy, in the Europe region.
How does San Camillo IRCCS make money?
Three revenue lines are on record. National Health Service (SSN) Reimbursement is the primary driver. The others are government Research Grants and 5×1000 Tax Donation.
Who are San Camillo IRCCS's main competitors?
Direct peers on record are IRCCS Fondazione Santa Lucia, IRCCS Centro Neurolesi Bonino Pulejo, Institut Guttmann, Craig Hospital and Burke Neurological Institute. Broad incumbents are Shirley Ryan AbilityLab, Kessler Institute for Rehabilitation and TIRR Memorial Hermann. Regional players are National Rehabilitation Hospital (Dublin) and Royal Hospital for Neuro-disability.
Does San Camillo IRCCS have an API?
No public API is recorded for San Camillo IRCCS.
What industry is San Camillo IRCCS in?
San Camillo IRCCS's product category is Neurorehabilitation Hospital Services. Its primary akta.pro industry code is HLAFAFAH, Neurorehabilitation Centers, with a secondary code of HLAFAFAA, Inpatient Rehabilitation Facilities (IRF). Its NAICS code is 62311 and its SIC code is 8051.